Rectal Bleeding Significantly Increases Colon Cancer Risk by Nearly 9×

Select Language:

Here’s the rewritten version in American English, with a natural, human tone and unique phrasing:

—

For many years, colorectal cancer was viewed primarily as a disease affecting older adults. Medical professionals typically targeted screening efforts at individuals over 50, under the assumption that risk increased with age.

However, this understanding has begun to shift. Globally, especially in developed nations, a rising number of young adults are being diagnosed with colorectal cancer more than ever before.

This trend has raised concerns among healthcare providers and researchers alike, because many younger individuals don’t qualify for routine screening programs. As a result, cancers might go unnoticed until symptoms appear and the disease has advanced.

A recent study points out one symptom that might be particularly important for young adults and their doctors to take seriously: rectal bleeding.

Colorectal cancer develops in the colon or rectum, parts of the large intestine. It often starts as small growths called polyps, which can slowly turn into cancer over time. When detected early, treatment is often highly successful. Unfortunately, many people ignore early warning signs or dismiss their symptoms as minor issues like hemorrhoids.

The study examined 443 patients under age 50 who had colonoscopies at the University of Louisville Health System between 2021 and 2023. A colonoscopy is a procedure where doctors use a flexible camera to look inside the colon and rectum, making it one of the most effective methods for detecting colorectal cancer and precancerous growths.

Out of these patients, 195—about 44%—were diagnosed with early-onset colorectal cancer, while 248 had normal colonoscopy results.

When the researchers analyzed the data, one thing stood out clearly: patients who reported rectal bleeding prior to their colonoscopy were significantly more likely to be diagnosed with colorectal cancer. In fact, the presence of rectal bleeding increased the odds of a cancer diagnosis by about 8.5 times.

This is especially significant because many young adults might brush off rectal bleeding as a minor issue. Some may feel uncomfortable discussing it with a doctor, or assume it’s due to benign causes like hemorrhoids. The study suggests this kind of assumption could be risky.

Interestingly, many of the younger patients diagnosed with colorectal cancer lacked traditional risk factors. For example, a family history of colorectal cancer is often seen as a strong predictor, but many of these patients had no known relatives with the disease.

Dr. Sandra Kavalukas, a colorectal surgeon and one of the study’s authors, noted that she often treats younger patients with colorectal cancer who have no family history at all. The findings help answer a key question many doctors face: when should younger patients, even those below the typical screening age, get screened with a colonoscopy?

The data indicates that rectal bleeding alone should be a compelling reason to pursue further testing, regardless of age. A young adult experiencing rectal bleeding might benefit from a colonoscopy even if they have no genetic or family risk factors.

Symptoms played a critical role in identifying cancer cases as well. About 88% of those diagnosed had undergone colonoscopy because they were experiencing symptoms, compared to only 55% of patients without cancer who underwent screening due to symptoms.

This highlights how symptoms can serve as important indicators for who may need more immediate evaluation. Among these, rectal bleeding appears to be one of the most vital warning signs.

The study also examined genetic risk factors and found that only 13% of the cancer patients carried common genetic markers linked to hereditary cancer syndromes. This suggests most cases couldn’t be explained by inherited genetic predispositions alone.

Furthermore, having a family history only roughly doubled the risk, whereas rectal bleeding increased the likelihood of cancer by over eight times.

Another noteworthy finding was that former smokers were nearly twice as likely to have colorectal cancer compared to those who never smoked, hinting that lifestyle choices, though needing further study, may influence rising rates of early-onset disease.

Dr. Kavalukas explained it with a practical example: if a 35-year-old experiences rectal pain without bleeding, a colonoscopy might not be necessary. But if that same individual reports rectal bleeding, the concern level rises substantially. In such cases, early detection through colonoscopy can be crucial for a better prognosis.

The current guidelines from the U.S. Preventive Services Task Force suggest starting regular screening at age 45 for average-risk individuals. However, many younger adults aren’t screened until symptoms develop, which can delay diagnosis.

As the number of early-onset colorectal cancer cases grows, experts believe symptoms like rectal bleeding should influence screening decisions more heavily. A larger study is now underway to create a straightforward risk calculator, aiming to help physicians identify which young patients might benefit most from a colonoscopy based on their symptoms and individual risk factors.

The key takeaway from this research is clear: rectal bleeding should never be dismissed, even in seemingly healthy young adults with no family history. Recognizing this symptom promptly and seeking medical advice early can lead to earlier diagnoses, more effective treatments, and potentially save lives.